Given the fact that copeptin assessment is able to add valuable predictive information beyond clinical variables, it could significantly enhance the discriminatory accuracy of widely utilized validated prognostic scores, thus optimizing overall stroke management. The gene discussed is AVP; the disease is Stroke.